miRNA Profiling of Cholesteatoma-Derived Exosomes Reveals Exosomal miR-223-3p and miR-142-5p as Potential Biomarkers for Acquired Middle Ear CholesteatomaOA
Objectives Acquired cholesteatoma is an abnormal and invasive growth of keratinized squamous epithelial cells in the middle ear.The study aims to explore the role of exosomal miRNAs in the pathogenesis of acquired cholesteatoma and their potential in clinical application.Methods Cholesteatoma and matched retroauricular skin samples were collected from 14 patients and exosomes were directly isolated from tissues.The specific exosomal miRNA expression pattern in cholesteatoma was determined through miRNA sequencing.The potential roles of differentially expressed miRNAs(DE-miRNAs)were investigated using Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)analyses.The enriched pathways of the top nine DE-miRNAs were further explored.Furthermore,the expression levels of these DE-miRNAs were validated in plasma-derived exosomes from 12 cholesteatoma patients,6 chronic otitis media patients,and 4 healthy individuals to identify the candidate biomarkers for cholesteatoma.Results Tissue-derived exosomes were successfully extracted from cholesteatoma and normal skin tissues.We found 14 upregulated miRNAs and 25 downregulated miRNAs in the cholesteatoma-derived exosomes.Bioinformatics analysis indicated that the DE-miRNAs participated in multiple biological processes,cell components,and molecular functions.The differential expression of hsa-miR-223-3p and hsa-miR-142-5p was verified in plasma-derived exosomes from cholesteatoma patients,and they showed a modest ability to distinguish between cholesteatoma and normal samples(AUC=0.81 and AUC=0.84,respectively).We further identified the potential functions of these two miRNAs in cholesteatoma pathogenesis.Conclusion Our study is the first to explore the specific exosomal miRNA profile of acquired cholesteatoma tissue.Exosomal miR-223-3p and miR-142-5p can be considered as promising biomarkers for acquired middle ear cholesteatoma.
Qi Tang;Meng-Yao Xie;Shu Wang;Zhi-Yuan Wu;Zhi-Jin Han;Chen Li;Shu-Yi Wang;Yuan Cao;Yu-Run Chen;Bin Wang;Ying-Ying Shang;Xiao-Wu Huang;Hua Yang
Department of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Otolaryngology,Shenzhen Hospital,Southern Medical University,Shenzhen,ChinaDepartment of Otolaryngology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
医药卫生
biomarkerscholesteatomamicroRNAlplasma-derived exosomestissue-derived exosomes
《World Journal of Otorhinolaryngology-Head and Neck Surgery》 2026 (4)
P.442-452,11
supported by the Beijing Natural Science Foundation of Youth Fund(Grant No.7234382)the Natural Science Foundation of Beijing Municipality,China(Grant no.7222128)National High Level Hospital Clinical Research Funding(Grant no.2022-PUMCH-095).
评论